Stay updated on PF-06939926 Safety/Efficacy in Duchenne Muscular Dystrophy Clinical Trial
Sign up to get notified when there's something new on the PF-06939926 Safety/Efficacy in Duchenne Muscular Dystrophy Clinical Trial page.

Latest updates to the PF-06939926 Safety/Efficacy in Duchenne Muscular Dystrophy Clinical Trial page
- Check2 days agoChange DetectedThe page revision updated from v3.3.3 to v3.3.4, indicating a minor update to the site metadata. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check9 days agoChange DetectedAdded two new sites in Salt Lake City (University of Utah Hospital and Primary Children's Hospital), bringing the total number of study locations to 53.SummaryDifference0.3%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedLocations section expanded with new study sites across multiple countries (US, Canada, Australia, several European and Asian countries, and others) and added city-level centers. The update provides detailed participating centers and locations for the Duchenne Muscular Dystrophy study.SummaryDifference2%

- Check52 days agoChange Detected- Revision: v3.3.2 was added and Revision: v3.2.0 was removed.SummaryDifference0.0%

- Check59 days agoChange DetectedRemoved the banner about government funding status and potential downtime. The study details and participation information remain unchanged.SummaryDifference0.3%

- Check81 days agoChange DetectedMinor UI adjustments and date updates were observed on the Study Details page, with core study content and outcomes remaining unchanged.SummaryDifference0.3%

Stay in the know with updates to PF-06939926 Safety/Efficacy in Duchenne Muscular Dystrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-06939926 Safety/Efficacy in Duchenne Muscular Dystrophy Clinical Trial page.